Skip to main content
. 2024 Sep 24;16(19):3251. doi: 10.3390/cancers16193251
cDC1 type 1 CD103+ dendritic cells
cDCV type 1 CD103⁺ dendritic cell vaccine
MoDCV monocyte-derived DC vaccine
TdLNs tumor-draining lymph nodes
DC dendritic cells
Flt-3L human FMS-like tyrosine kinase 3 ligand
PMA phorbol 12-myristate 13 acetate
DAPI 4,6-diamino-2-phenylindole
ANOVA analysis of variance